Day: September 3, 2025

Almadex Provides Exploration and Drilling Update and Plans for Remainder of 2025

Written by Customer Service on September 3, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, Sept. 03, 2025 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) is pleased to provide an update on recent and planned exploration activity for the remainder of 2025. Drilling ActivitiesAs previously announced upon commencement (see Almadex news release of June 17, 2025), Almadex has now completed the drilling of two diamond drill holes at its wholly owned porphyry lithocap target on the Paradise Project, Nevada. Drilling of a third hole will commence shortly. Assays are pending from this program. When complete results are received and interpreted the Company will provide an update. Almadex also anticipates that a first pass drilling program on one of the projects optioned by Azucar Minerals (see Almadex news release of May 1, 2025) upon approval...

PharmaCorp to Acquire Two Pharmacies in Western Canada

Written by Customer Service on September 3, 2025. Posted in Mergers And Acquisitions.

SASKATOON, Saskatchewan, Sept. 03, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into definitive share purchase agreements, each dated August 29, 2025 (the “Agreements”), to acquire from the same arm’s length vendors (the “Vendors”) a 100% interest in two PharmaChoice Canada bannered pharmacies located in Western Canada, one of which includes the associated lands and building (the “Acquisitions”). The aggregate purchase price for the Acquisitions is $3,400,000, subject to customary adjustments (the “Purchase Price”). In accordance with the Agreements, 75% of the Purchase Price will be satisfied with cash on hand and 25% will be satisfied by the issuance of common shares of PharmaCorp (the “Common Shares”). The deemed price for the Common Shares...

EPH European Property Holdings PLC Profit / Loss Warning – EPH expects net profit in its consolidated accounts for the 1HY 2025 compared to the previous year

Written by Customer Service on September 3, 2025. Posted in Earnings Releases And Operating Results.

03 September 2025, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR EPH European Property Holdings PLC (“EPH”, the “Company”) would like to announce that the Company expects a net profit of approximately EUR 4-5 million for the first half year 2025, compared to a net loss of EUR 13.89 million for the same period a year earlier. The main factor behind this positive change in financial results is a gain on revaluation of investment properties of approximately EUR 3 million, recognized in the reporting period, resulting primarily from a slight increase in market rental rates and stabilization of discount and capitalization rates at the level of YE 2024. In HY 2024, EPH recognised a loss of EUR 20 million on revaluation of investment properties as a result of rising capitalization and discount rates during that period. The revenue...

ChipFoundry Acquires Efabless Assets to Propel Custom Silicon Innovation

Written by Customer Service on September 3, 2025. Posted in Mergers And Acquisitions.

SAN CARLOS, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Umbralogic Technologies LLC, operating as ChipFoundry, today announced the successful acquisition of Efabless’ intellectual property and technology assets, including a portfolio of 15 issued patents and 3 pending applications. This strategic purchase strengthens ChipFoundry’s commitment to making custom silicon accessible to a broader market of innovators, researchers, and educators worldwide. ChipFoundry provides a platform designed to democratize silicon chip design and manufacturing by lowering the barriers to custom chip development. It achieves this by providing affordable prototyping and fabrication, standardized design templates, and a collaborative ecosystem that empowers product innovators, startups, researchers, and educational institutions to bring their silicon...

Microbix Hosts Ontario Minister Stephen Crawford

Written by Customer Service on September 3, 2025. Posted in Public Companies.

Site Visit & Discussions at Biotech Manufacturing Facilities in Mississauga MISSISSAUGA, Ontario, Sept. 03, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces its hosting of the Honourable Stephen Crawford, Ontario’s Minister of Public and Business Service Delivery and Procurement, for a site visit to tour the company’s advanced biotechnology development and manufacturing facilities and discuss how next generation diagnostics can improve health outcomes while reducing healthcare costs for Ontarians. The Province of Ontario has been a strong supporter of Microbix in recent years, with over C$ 2.0 million of grant funding from its Ontario Together Funds (OTF & OTF2). Those successful initiatives have helped build state-of-the-art...

Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients

Written by Customer Service on September 3, 2025. Posted in Public Companies.

First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal thyroid function (T3 and T4 less than the upper limit of normal) at the end of the six-month follow-up period Of the 17 responders to therapy, ~50% (8/17) achieved anti-thyroid drug (ATD) free remission at six months following end of batoclimab treatment Two potentially registrational trials for IMVT-1402 in Graves’ disease are currently enrolling with topline readouts expected in 2027 Roivant to host investor call to discuss these updates today, September 3, 2025, at 4:30 p.m. EDTNEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling...

Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves’ Disease Patients

Written by Customer Service on September 3, 2025. Posted in Public Companies.

Vivakor Sets Payment Date of Special Dividend for September 26, 2025

Written by Customer Service on September 3, 2025. Posted in Public Companies.

Dallas, TX, Sept. 03, 2025 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse, and remediation services, today announced the payment date of the previously-announced special dividend to Vivakor shareholders as September 26, 2025. In accordance with NASDAQ listing rules, the dividend will be paid to holders of record of common shares of the Company as of the previously announced ex-dividend date of September 5, 2025. Vivakor Chairman, President and CEO James Ballengee commented, “The payment of this dividend prior to the current quarter’s end provides immediate value to Vivakor shareholders and demonstrates our commitment to improving Vivakor’s balance sheet and focus our efforts on our core crude oil transportation and facilities...

AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem

Written by Customer Service on September 3, 2025. Posted in Public Companies.

AlphaTON Capital Unlocks Public Market Access to Toncoin (TON) and Telegram’s Billion-User Ecosystem Brittany Kaiser, pioneer in data protection, digital assets, and the public equity markets appointed Chief Executive Officer and Board Member Formerly Portage Biotech Inc. (Nasdaq: PRTG), Renamed AlphaTON Capital Corp with new ticker symbol “ATON” effective as of the opening of the market on September 4, 2025 Initial Financing to Acquire ~$100M TON tokens and Start Corporate Treasury; expected to close on or about September 5, 2025DOVER, Del., Sept. 03, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital Corp. (“AlphaTON Capital” or the “Company”, formerly Portage Biotech Inc.) (Nasdaq: PRTG, ATON), today announced a financing to acquire ~$100 million TON tokens and establish a specialized digital asset treasury company dedicated to building...

PROACTIS SA -Press release (nomination M. Larsen) 03.09.2025

Written by Customer Service on September 3, 2025. Posted in Public Companies.

Press release Appointment of Maria LARSEN to the board of directors of PROACTIS SA to replace Lucy FOX, who has resigned PARIS, France – (3 September 2025) — Under the terms of the Board of Directors of the company PROACTIS SA (code ISIN : FR0004052561) held on the 31st of August 2025, Mrs. Maria LARSEN was co-opted as a director to replace Mrs. Lucy FOX, who resigned. Shareholders will be asked to approve this appointment at the next Annual General Meeting called to approve the financial statements. Maria LARSEN joined the PROACTIS Group in April 2025 as Customer Success and Transformation Director. Maria’s diverse career spans leadership roles within the British Army, humanitarian aid and transformational management consultancy. She brings exceptional leadership experience and a deep passion for stakeholder engagement. Maria LARSEN...

Day: September 3, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals